Patents by Inventor Ana de Vera

Ana de Vera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosage regimen of an S1P receptor modulator
    Patent number: 11759436
    Abstract: The present invention relates to a dosage regimen of an S1P receptor modulator or agonist in the course of the treatment of patients suffering from multiple sclerosis. Specifically, the present invention relates to testing a patient for a history of infection caused by varicella zoster virus and vaccinating the patient prior to administration of an S1P receptor modulator or agonist.
    Type: Grant
    Filed: January 10, 2020
    Date of Patent: September 19, 2023
    Assignee: Novartis AG
    Inventors: Craig Boulton, Pascale Burtin, Olivier David, Ana de Vera, Thomas Dumortier, Irene Hunt, Robert Schmouder, William C. Collins
  • DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
    Publication number: 20230086687
    Abstract: S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.
    Type: Application
    Filed: April 28, 2022
    Publication date: March 23, 2023
    Inventors: Craig Boulton, Pascale Burtin, Olivier David, Ana de Vera, Thomas Dumortier, Irene Hunt, Robert Schmouder
  • DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
    Publication number: 20200222338
    Abstract: S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.
    Type: Application
    Filed: January 10, 2020
    Publication date: July 16, 2020
    Inventors: Craig Boulton, Pascale BURTIN, Olivier DAVID, Ana de VERA, Thomas DUMORTIER, Irene HUNT, Robert SCHMOUDER, William C. COLLINS
  • Dosage regimen of an S1P receptor modulator
    Patent number: 10543179
    Abstract: The present invention relates to a dosage regimen of an S1P receptor modulator or agonist in the course of the treatment of patients suffering from an inflammatory or autoimmune disorder, for example multiple sclerosis. Specifically, the present invention relates to testing a patient for a history of infection and vaccinating the patient prior to administration of fingolimod or a pharmaceutically acceptable salt thereof at a daily dosage of 0.5 mg.
    Type: Grant
    Filed: May 23, 2018
    Date of Patent: January 28, 2020
    Inventors: Craig Boulton, Pascale Burtin, Olivier David, Ana de Vera, Thomas Dumortier, Irene Hunt, Robert Schmouder, William C. Collins
  • DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
    Publication number: 20180263930
    Abstract: S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.
    Type: Application
    Filed: May 23, 2018
    Publication date: September 20, 2018
    Inventors: Craig Boulton, Pascale Burtin, Olivier David, Ana de Vera, Thomas Dumortier, Irene Hunt, Robert Schmouder
  • DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
    Publication number: 20180263929
    Abstract: S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.
    Type: Application
    Filed: May 23, 2018
    Publication date: September 20, 2018
    Inventors: Craig Boulton, Pascale BURTIN, Olivier DAVID, Ana de VERA, Thomas DUMORTIER, Irene HUNT, Robert SCHMOUDER
  • DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
    Publication number: 20170304226
    Abstract: S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.
    Type: Application
    Filed: July 11, 2017
    Publication date: October 26, 2017
    Inventors: Craig Boulton, Pascale BURTIN, Olivier DAVID, Ana de VERA, Thomas DUMORTIER, Irene HUNT, Robert SCHMOUDER
  • DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
    Publication number: 20160256416
    Abstract: S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.
    Type: Application
    Filed: May 12, 2016
    Publication date: September 8, 2016
    Applicant: Novartis AG
    Inventors: Craig Boulton, Pascale Burtin, Olivier David, Ana de Vera, Thomas Dumortier, Irene Hunt, Robert Schmouder
  • USE OF AN S1P RECEPTOR AGONIST
    Publication number: 20160089348
    Abstract: The present invention relates to new uses of S1P receptor modulator or agonist such as fingolimod, for reducing or delaying the progression of cerebral atrophy.
    Type: Application
    Filed: December 2, 2015
    Publication date: March 31, 2016
    Inventors: Shreeram Aradhye, Ana DE VERA
  • DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
    Publication number: 20140187516
    Abstract: S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.
    Type: Application
    Filed: February 10, 2014
    Publication date: July 3, 2014
    Applicant: NOVARTIS AG
    Inventors: Craig BOULTON, Pascale BURTIN, Olivier DAVID, Ana de VERA, Thomas DUMORTIER, Irene HUNT, Robert SCHMOUDER
  • Use of an S1P Receptor Agonist
    Publication number: 20130253066
    Abstract: The present invention relates to new uses of S1P receptor modulator or agonist such as fingolimod, for reducing or delaying the progression of cerebral atrophy.
    Type: Application
    Filed: May 20, 2013
    Publication date: September 26, 2013
    Inventors: Shreeram Aradhye, Ana DE VERA
  • DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
    Publication number: 20120264719
    Abstract: S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.
    Type: Application
    Filed: September 20, 2010
    Publication date: October 18, 2012
    Inventors: Craig Boulton, Pascale Burtin, Olivier David, Ana de Vera, Thomas Dumortier, Irene Hunt, Robert Schmouder
  • Use of an S1P Receptor Agonist
    Publication number: 20110124605
    Abstract: The present invention relates to new uses of S1P receptor modulator or agonist such as fingolimod, for reducing or delaying the progression of cerebral atrophy.
    Type: Application
    Filed: November 19, 2010
    Publication date: May 26, 2011
    Inventors: Shreeram Aradhye, Ana de Vera